Anti-Rhinovirus 16 [Clone R16-7]

Product No.: 18758

- -
- -
Clone
R16-7
Target
Rhinovirus 16
Formats AvailableView All
Product Type
Monoclonal
Isotype
Mouse IgG2b
Applications
IHC
,
WB

- -
- -
Select Product Size

Data

Immunoblotting: use at 2-5ug/ml. Lysates of HeLa cells infected with RV serotypes 1A, 2, 14, 16, or 49 and blotted with #18758.Immunoblotting: use at 2-5ug/ml. Lysates of HeLa cells infected with RV serotypes 1A, 2, 14, 16, or 49 and blotted with #18758.
Immunohistochemistry: use at 1-10ug/ml. IHC staining for viral capsid protein with #18758: (A) Uninfected HeLa cells, (B) HRV16-infected HeLa cells, (C) Negative bronchial biopsy section, (D) Positive bronchial biopsy section.Immunohistochemistry: use at 1-10ug/ml. IHC staining for viral capsid protein with #18758: (A) Uninfected HeLa cells, (B) HRV16-infected HeLa cells, (C) Negative bronchial biopsy section, (D) Positive bronchial biopsy section.
- -
- -

Antibody Details

Product Details

Reactive Species
Rhinovirus 16
Host Species
Mouse
Immunogen
Purified HRV16
Product Concentration
Lot Specific
Formulation
This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added.
State of Matter
Liquid
Product Preparation
Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Upon initial thawing, appropriately aliquot and store at -80°C. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
Immunoblotting: use at 2-5ug/mL.

Immunohistochemistry: use at 1-10ug/mL.

These are recommended concentrations;

Endusers should determine optimal concentrations for their applications.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
This non-neutralizing antibody recognizes capsid protein VP2 (mw ~30kDa) of HRV16, HRV1A, and HRV39 and VP2 precursors VP0 (mw ~37kDa) and P1 (mw ~90kDa).
Background
Rhinoviruses (HRV), members of the Picornaviridae family, are ubiquitous and highly prevalent RNA viruses. These small, non-enveloped pathogens are characterized by their icosahedral capsid and a single-stranded, positive-sense RNA genome. The viral genome uniquely encodes a single polyprotein that is subsequently cleaved by viral proteases into essential structural and non-structural proteins, vital for viral replication and assembly.

With over 100 known serotypes, Human Rhinoviruses are the primary cause of the common cold, leading to millions of upper airway infections annually. Beyond acute symptoms, HRV infections pose a significant health burden by exacerbating lower airway symptoms in vulnerable patient populations. They are well-documented triggers for severe complications in individuals suffering from asthma, cystic fibrosis (CF), and chronic obstructive pulmonary disease (COPD), often leading to increased hospitalizations and diminished quality of life.

Our Anti-Rhinovirus 16 monoclonal antibody, Clone R16-7, is specifically developed to target Rhinovirus 16. This highly specific tool is indispensable for researchers investigating HRV pathogenesis, viral diagnostics, and the development of new antiviral therapies or vaccines. Leverage Clone R16-7 for precise detection and characterization of Rhinovirus 16 in your studies.
Research Area
Infectious Disease

References & Citations

1) Mosser AG et al. 2002 J Infect Dis 185: 734.
2) Mosser AG et al. 2005 Am J Respir Crit Care Med 171: 645.
3) Jurgeit A et a. 2010 Virology J 7: 264.
4) Chattoraj SS et al. 2011 Infect Immun 79: 4131.
IHC
General Western Blot Protocol

Certificate of Analysis

Formats Available

- -
- -
Prod No.
Description
18758
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.